(Q34450224)

English

Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

lupus erythematosus

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

0 references

author name string

Horai Y

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ishizaki T

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sasaki T

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Koya G

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Matsuyama K

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Iguchi S

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 March 1982

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

361-374

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Pharmacokinetics of isoniazid in the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Apparent predisposition to systemic lupus erythematosus in Chinese patients in West Malaysia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

The discrimination of phenotypes for rate of disappearance of isonicotinoyl hydrazide from serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

The polymorphic acetylation of dapsone in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

A filter paper method for determining isoniazid acetylator phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Isoniazid inactivation in Finns and Lapps as demonstrated by various methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Acetylator phenotype in spontaneous SLE and rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Clinical Pharmacokinetics of Isoniazid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Disease and Acetylation Polymorphism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Acetylator phenotype in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Aromatic amines and hydrazines drug acetylation, and lupus erythematodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Antibodies to Nuclear Antigens in Patients Treated with Procainamide or Acetylprocainamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

Clinical consequences of polymorphic acetylation of basic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

6 July 2018

GENETICS OF ISONIAZID METABOLISM IN CAUCASIAN, NEGRO, AND JAPANESE POPULATIONS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01387.X

21 January 2018

Genetical and geographic studies on isoniazid inactivation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01387.X

21 January 2018

APPLICATION OF DRUG METABOLISM TO DRUG TOXICITY STUDIES

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402126

27 October 2018

Isoniazid and ethionamide serum levels and inactivation in Finnish subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of the acetylator phenotype from the ratio of the urinary excretion of acetylisoniazid to acid-labile isoniazid: a study in finnish lapland

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The acetylator phenotype of patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous reactions to drugs, acetylation phenotype and HLA antigens in patients with and without systemic lupus erythematosus (SLE)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of isoniazid metabolism in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spectrophotofluorometric assay for isoniazid and acetyl isoniazid in plasma adapted to pediatric studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous systemic lupus erythematosus and acelylator phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic drug acetylation and oxidation: effects of aging in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoacetylhydrazine as a metabolite of isoniazid in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative determination of hydrazines derived from isoniazid in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal distribution of acetylation phenotypes in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex effects in systemic lupus erythematosus: a clue to pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slow acetylation phenotype in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acetylator phenotype in idiopathic systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acetylator phenotype and metabolic disposition of isoniazid in japanese patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution and excretion of radioactive isoniazid in tuberculous patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of C14-isoniazid in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of human patterns of isoniazid metabolism using an intravenous fall-off technique with a chemical method

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic control of isoniazid metabolism in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/7059436

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.1982.TB01387.X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34450224&oldid=1602977198"